サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468236

核医学放射性同位元素の世界市場：製品別、用途別、エンドユーザー別、地域別、2024～2032年

Nuclear Medicine Radioisotopes Market by Product, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
核医学放射性同位元素の世界市場：製品別、用途別、エンドユーザー別、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核医学放射性同位元素の市場規模は、2023年に73億米ドルに達し、2024～2032年にかけてCAGR 7.51%で成長し、2032年までに142億米ドルに達すると予測されています。がん罹患率の上昇、核医薬需要の増大、さまざまな技術進歩が市場を牽引する主な要因です。

核医学放射性同位元素は放射性物質であり、様々な病状の診断や治療に使用されます。これらの放射性同位元素は放射線を放出し、それを検出・測定することで体内の臓器や組織の構造や機能に関する情報を得ることができます。放射性同位元素は主に診断および治療用途に利用されます。診断用途では、体内の臓器やシステムの画像を作成するために放射性同位元素が使用されます。これにより、ヘルスケア専門家は異常を特定し、がん、心臓病、神経疾患などの状態を診断することができます。一方、治療用途では、放射性同位元素は体内のがん細胞やその他の異常組織に標的放射線療法を行うために使用されます。さらに、核医学放射性同位元素は非侵襲的で、外科的切開やその他の侵襲的処置を必要とせず、化学療法や放射線療法などの治療法に比べて副作用や合併症のリスクが低いため、従来の診断・治療法に比べていくつかの利点があります。こうした利点から、核医学放射性同位元素は世界中の病院で広く利用されています。

核医学放射性同位元素市場の動向：

核医学放射性同位元素市場は、主にがん患者の増加によって牽引されています。核医学放射性同位元素は、PETスキャンなどのがん診断ソリューションや治療療法に広く使用されています。加えて、核医学放射性同位元素の使用を必要とするがん、心臓病、神経疾患などの慢性疾患に罹患しやすい老年人口が増加していることも、成長を促す大きな要因となっています。これに加えて、さまざまな技術の進歩により、核医学放射性同位元素の新しく改良された診断・治療用途が開発されています。このことは、核医学への投資と需要の増加と相まって、市場の成長にプラスの影響を与えています。政府および民間組織は、核医学技術の研究開発に多額の投資を行っており、これが新製品および用途の創出につながり、ひいては市場成長の原動力となっています。さらに、放射線や放射線療法に対する患者の意識の高まりも市場を後押ししています。さらに、医療費の増加、先進的な製品の発売、主国企業による研究開発活動の活発化なども、良好な市場見通しを生み出す要因となっています。

本レポートで扱う主な質問

  • 世界の核医学放射性同位元素市場はこれまでどのように推移してきたのか？
  • 世界の核医学放射性同位元素市場における促進要因、抑制要因、機会は何か？
  • 促進要因、抑制要因、機会が世界の核医学放射性同位元素市場に与える影響は？
  • 主要な地域市場は？
  • 核医学放射性同位元素市場で最も魅力的な国は？
  • 製品別の市場内訳は？
  • 核医学放射性同位元素市場で最も魅力的な製品は？
  • 用途別の市場内訳は？
  • 核医学放射性同位元素市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • 核医学放射性同位元素市場で最も魅力的なエンドユーザーは？
  • 世界の核医学放射性同位元素市場の競合構造は？
  • 世界の核医学放射性同位元素市場の主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データ情報源
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の核医学放射性同位元素市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 診断薬
    • 市場動向
    • 主要セグメント
      • Technetium-99m (Tc-99m)
      • Gallium-67
      • Thallium-201
      • Fluorine-18
      • その他
    • 市場予測
  • 治療薬
    • 市場動向
    • 主要セグメント
      • Rhenium-186
      • Iodine-131
      • Samarium-153
      • Yttrium-90
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 循環器
  • 腫瘍学
  • 甲状腺
  • 神経
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • 診断センター
  • 専門クリニック
  • 教育・研究機関
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bracco S.p.A.
    • Bruce Power Inc.
    • Cardinal Health Inc.
    • China Isotope & Radiation Corporation（China National Nuclear Corporation）
    • Curium Pharma
    • Eckert & Ziegler
    • Nordion（Canada）Inc（Sotera Health Company）
    • NorthStar Medical Radioisotopes, LLC
    • NTP Radioisotopes SOC Ltd
    • Shine Technologies LLC
図表

List of Figures

  • Figure 1: Global: Nuclear Medicine Radioisotopes Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Radioisotopes Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Nuclear Medicine Radioisotopes Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Nuclear Medicine Radioisotopes Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Nuclear Medicine Radioisotopes Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Nuclear Medicine Radioisotopes Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Nuclear Medicine Radioisotopes (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Nuclear Medicine Radioisotopes (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Nuclear Medicine Radioisotopes (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Nuclear Medicine Radioisotopes (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Nuclear Medicine Radioisotopes (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Nuclear Medicine Radioisotopes (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Nuclear Medicine Radioisotopes (Thyroid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Nuclear Medicine Radioisotopes (Thyroid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Nuclear Medicine Radioisotopes (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Nuclear Medicine Radioisotopes (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Nuclear Medicine Radioisotopes (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Nuclear Medicine Radioisotopes (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Nuclear Medicine Radioisotopes (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Nuclear Medicine Radioisotopes (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Nuclear Medicine Radioisotopes (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Nuclear Medicine Radioisotopes (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Nuclear Medicine Radioisotopes (Education and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Nuclear Medicine Radioisotopes (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Nuclear Medicine Radioisotopes (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Nuclear Medicine Radioisotopes Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Nuclear Medicine Radioisotopes Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Nuclear Medicine Radioisotopes Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Nuclear Medicine Radioisotopes Industry: Value Chain Analysis
  • Figure 83: Global: Nuclear Medicine Radioisotopes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Radioisotopes Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Nuclear Medicine Radioisotopes Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Nuclear Medicine Radioisotopes Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Radioisotopes Market: Key Players
目次
Product Code: SR112024A7532

The global nuclear medicine radioisotopes market size reached US$ 7.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The rising prevalence of cancer, the escalating demand for nuclear medicines, and various technological advancements represent some of the key factors driving the market.

Nuclear medicine radioisotopes are radioactive substances that are used in diagnostic and therapeutic procedures for various medical conditions. These radioisotopes emit radiation, which can be detected and measured to provide information about the structure and function of organs and tissues in the body. They are mainly utilized for diagnostic and therapeutic applications. In diagnostic applications, radioisotopes are employed to create images of the body's internal organs and systems. This allows healthcare professionals to identify abnormalities and diagnose conditions such as cancer, heart disease, and neurological disorders. On the other hand, in therapeutic applications, radioisotopes are used to deliver targeted radiation therapy to cancer cells or other abnormal tissues in the body. Moreover, nuclear medicine radioisotopes have several advantages over traditional diagnostic and therapeutic procedures as they are non-invasive, do not require surgical incisions or other invasive procedures, and have a lower risk of side effects and complications compared to treatments such as chemotherapy or radiation therapy. Owing to these benefits, nuclear medicine radioisotopes are widely utilized in hospitals across the globe.

Nuclear Medicine Radioisotopes Market Trends:

The market is primarily driven by the growing prevalence of cancer among individuals. Nuclear medicine radioisotopes are widely used in cancer diagnosis solutions such as PET scans and treatment therapies. In addition, the rising geriatric population that is more susceptible to chronic diseases such as cancer, heart disease, and neurological disorders, which require the use of nuclear medicine radioisotopes, represents another major growth-inducing factor. Besides this, various technological advancements have led to the development of new and improved diagnostic and therapeutic applications of nuclear medicine radioisotopes. This, coupled with the increasing investment and demand for nuclear medicines, is positively influencing market growth. Governments and private organizations are investing heavily in the research and development of nuclear medicine technologies, leading to the creation of new products and applications, which in turn is driving the market growth. Moreover, the market is also propelled by the growing patient awareness about radiation and radiation therapy. Furthermore, the rising healthcare expenditure, the launch of advanced product variants, and increasing research and development activities conducted by key players are other factors creating a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nuclear medicine radioisotopes market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, application, and end user.

Product Insights:

Diagnostics

Technetium-99m (Tc-99m)

Gallium-67

Thallium-201

Fluorine-18

Others

Therapeutics

Rhenium-186

Iodine-131

Samarium-153

Yttrium-90

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the product. This includes diagnostics [technetium-99m (Tc-99m), gallium-67, thallium-201, fluorine-18, and others] and therapeutics (rhenium-186, iodine-131, samarium-153, yttrium-90, and others). According to the report, diagnostics (technetium-99m (Tc-99m) represented the largest segment.

Application Insights:

Cardiology

Oncology

Thyroid

Neurology

Others

A detailed breakup and analysis of the nuclear medicine radioisotopes market based on the application has also been provided in the report. This includes cardiology, oncology, thyroid, neurology, and others. According to the report, cardiology accounted for the largest market share.

End User Insights:

Hospitals

Diagnostic Centers

Specialty Clinics

Education and Research Institutes

Others

The report has provided a detailed breakup and analysis of the nuclear medicine radioisotopes market based on the end user. This includes hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for nuclear medicine radioisotopes. Some of the factors driving the North America nuclear medicine radioisotopes market included aging population, technological advancements, rising prevalence of cancer.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global nuclear medicine radioisotopes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bracco S.p.A., Bruce Power Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (China National Nuclear Corporation), Curium Pharma, Eckert & Ziegler, Nordion (Canada) Inc (Sotera Health Company), NorthStar Medical Radioisotopes, LLC, NTP Radioisotopes SOC Ltd.,Shine Technologies LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global nuclear medicine radioisotopes market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine radioisotopes market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine radioisotopes market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine radioisotopes market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the nuclear medicine radioisotopes market?
  • What is the competitive structure of the global nuclear medicine radioisotopes market?
  • Who are the key players/companies in the global nuclear medicine radioisotopes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Radioisotopes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Technetium-99m (Tc-99m)
      • 6.1.2.2 Gallium-67
      • 6.1.2.3 Thallium-201
      • 6.1.2.4 Fluorine-18
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Rhenium-186
      • 6.2.2.2 Iodine-131
      • 6.2.2.3 Samarium-153
      • 6.2.2.4 Yttrium-90
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Cardiology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Thyroid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neurology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Education and Research Institutes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bracco S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Bruce Power Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Cardinal Health Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 China Isotope & Radiation Corporation (China National Nuclear Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Curium Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Eckert & Ziegler
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nordion (Canada) Inc (Sotera Health Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 NorthStar Medical Radioisotopes, LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 NTP Radioisotopes SOC Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shine Technologies LLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.